Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · IEX Real-Time Price · USD
43.35
-1.31 (-2.93%)
At close: Mar 28, 2024, 4:00 PM
44.50
+1.15 (2.65%)
After-hours: Mar 28, 2024, 6:09 PM EDT

Ionis Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1994
Revenue
787.65587.37810.46729.261,123599.67514.18372.78283.7214.16
Upgrade
Revenue Growth (YoY)
34.10%-27.53%11.13%-35.04%87.20%16.63%37.93%31.40%32.47%45.41%
Upgrade
Cost of Revenue
9.1314.1210.8411.954.381.820000
Upgrade
Gross Profit
778.51573.25799.61717.321,118597.85514.18372.78283.7214.16
Upgrade
Selling, General & Admin
232.62150.3186.35354.32286.64244.62108.4948.6237.1720.14
Upgrade
Research & Development
899.63833.15643.45535.08465.69414.6374.64344.32322.29241.75
Upgrade
Operating Expenses
1,132983.44829.8889.4752.33659.23483.13392.94359.47261.89
Upgrade
Operating Income
-353.73-410.19-30.19-172.08365.88-61.3731.05-20.16-75.76-47.73
Upgrade
Interest Expense / Income
81.468.129.359.5112.4444.7944.7538.836.7322.21
Upgrade
Other Expense / Income
-101.22-160.33-10.39-82.5223.79-88.76-8.07-1.49-24.59-15.55
Upgrade
Pretax Income
-333.97-257.99-29.15-99.07329.65-17.4-5.63-57.47-87.91-54.39
Upgrade
Income Tax
32.3211.74-0.55345.1951.51-291.14-5.982.930.37-15.41
Upgrade
Net Income
-366.29-269.72-28.6-444.26278.14273.740.35-60.4-88.28-38.98
Upgrade
Net Income Growth
----1.61%79015.90%----
Upgrade
Shares Outstanding (Basic)
143142141140140132124121120118
Upgrade
Shares Outstanding (Diluted)
143142141140153134126121120118
Upgrade
Shares Change
0.95%0.59%1.01%-8.85%14.25%6.31%4.27%1.01%1.72%6.51%
Upgrade
EPS (Basic)
-2.56-1.90-0.20-3.182.002.090.15-0.50-0.74-0.33
Upgrade
EPS (Diluted)
-2.56-1.90-0.20-3.181.902.070.15-0.50-0.74-0.33
Upgrade
EPS Growth
-----8.21%1280.00%----
Upgrade
Free Cash Flow
-331.3-36.0118.840.77314.72589.3139.39-119.2113.43-1.23
Upgrade
Free Cash Flow Per Share
-2.31-0.250.130.012.254.451.12-0.990.11-0.01
Upgrade
Gross Margin
98.84%97.60%98.66%98.36%99.61%99.70%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-44.91%-69.84%-3.72%-23.60%32.59%-10.23%6.04%-5.41%-26.70%-22.29%
Upgrade
Profit Margin
-46.50%-45.92%-3.53%-60.92%24.78%45.65%0.07%-16.20%-31.12%-18.20%
Upgrade
Free Cash Flow Margin
-42.06%-6.13%2.33%0.11%28.04%98.27%27.11%-31.98%4.73%-0.58%
Upgrade
Effective Tax Rate
----15.62%-----
Upgrade
EBITDA
-230.01-227.76-0.24-72.4356.1738.145.83-11.19-44.19-25.8
Upgrade
EBITDA Margin
-29.20%-38.78%-0.03%-9.93%31.73%6.35%8.91%-3.00%-15.58%-12.05%
Upgrade
Depreciation & Amortization
22.522.1119.5617.1614.0810.716.717.486.986.38
Upgrade
EBIT
-252.51-249.86-19.8-89.56342.0927.3939.12-18.67-51.17-32.18
Upgrade
EBIT Margin
-32.06%-42.54%-2.44%-12.28%30.47%4.57%7.61%-5.01%-18.04%-15.03%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).